Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

UBS Warburg Cuts St. Jude Medical to 'Reduce'


UBS Warburg downgraded St. Jude Medical (STJ) to reduce from hold.

Analyst David Lothson says the company is the best performing stock in the medical supply and device sector since March 31, 2000. He says the strength reflects a return to earnings per share consistency, combined with an acceleration in both sales and EPS growth, which are a function of a recovery in the company's implantable cardioverter-defibrillator (ICD) operations.

Lothson believes important new product offerings in ICDs by both Medtronic and Guidant will not be matched by St. Jude for at least one year. He also thinks the failure for St. Jude to beat consensus estimates could lead to selling pressure on the stock. Lothson cut his $85 12-month target to $65.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus